- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Health-risk Behaviours in New Zealand
Total 14572 results
-
PolyActiva Pty LtdCompletedOcular Hypertension | Open Angle GlaucomaNew Zealand
-
Elixir Medical CorporationCompletedCoronary Artery DiseaseNew Zealand
-
Kona Medical Inc.CompletedHypertensionCzech Republic, New Zealand
-
RWTH Aachen UniversityUnknown
-
TriReme Medical, LLCCompletedPeripheral Vascular DiseaseNew Zealand, Germany
-
Abiomed Inc.CompletedPatients Undergoing High Risk PCI.United States, Netherlands
-
National Cancer Institute (NCI)Active, not recruitingGanglioneuroblastoma | High Risk NeuroblastomaUnited States, New Zealand, Australia
-
University of New MexicoNational Institute of Mental Health (NIMH)CompletedPsychosis | Clinical High Risk for Psychosis | First Episode PsychosisUnited States
-
Crux BiomedicalCompletedPulmonary EmbolismNew Zealand, Australia
-
AtaCor Medical, Inc.CompletedConduction DefectNew Zealand, Paraguay, Czechia
-
Fisher and Paykel HealthcareCompletedObstructive Sleep Apnea | Positive Airway Pressure TherapyNew Zealand
-
University of ConnecticutNational Institute on Drug Abuse (NIDA); Yale University; APT Foundation, Inc.CompletedRisk Behavior | HIV | Medication AdherenceUnited States
-
Boston Scientific CorporationCryterion Medical, Inc.Completed
-
Abiomed Inc.Enrolling by invitationHigh-Risk Percutaneous Coronary InterventionUnited States
-
Tulane UniversityCompletedDepression | Cardiovascular Diseases | Hypertension | Obesity | Diabetes | Cancer | Nutrition Disorders | Physical Activity | Cardiovascular Risk FactorUnited States
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)Enrolling by invitationFirst Episode Psychosis (FEP) | Clinical High Risk for Psychosis (CHR)United States
-
National University Heart Centre, SingaporeAstraZenecaRecruitingAcute Coronary SyndromeAustralia, New Zealand, Singapore
-
University of RochesterNational Institute of Mental Health (NIMH)Completed
-
Yale UniversityCompleted
-
Yale UniversityTerminatedClinical High Risk for PsychosisUnited States
-
Alvotech Swiss AGCompletedHealthy Male SubjectsSouth Africa, Australia, New Zealand
-
NYU Langone HealthNational Institute on Drug Abuse (NIDA)Not yet recruitingHealth Services ResearchUnited States
-
Fisher and Paykel HealthcareCompletedObstructive Sleep Apnea | Sleep Disordered BreathingNew Zealand
-
Shockwave Medical, Inc.Active, not recruitingPeripheral Arterial DiseaseNew Zealand, Australia
-
Yale UniversityCompleted
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)CompletedFirst Episode Psychosis (FEP) | At Risk Mental State (ARMS)United States
-
Northwell HealthTerminatedHigh Risk MC4R Genotype | Low Risk MC4R Genotype | One Week or Less Antipsychotic Lifetime ExposureUnited States
-
Yale UniversityNational Institute on Drug Abuse (NIDA)CompletedRisk-Taking | Pre-natal Cocaine ExposureUnited States
-
Alleviant Medical, Inc.Active, not recruiting
-
University of RochesterNational Institute on Drug Abuse (NIDA)CompletedTobacco Dependence | Elevated Risk of Cardiovascular DiseaseUnited States
-
Micell TechnologiesCompletedFirst-In-Human Trial of the MiStent Drug-Eluting Stent (DES) in Coronary Artery Disease (DESSOLVE-I)Coronary Artery DiseaseBelgium, Australia, New Zealand
-
Carolyn LaucknerNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Not yet recruitingHIV Infections | Risk Behavior | Alcohol Use DisorderUnited States
-
Efemoral Medical, Inc.RecruitingVascular Diseases | Peripheral Arterial Disease | Stenosis | Femoropopliteal StenosisNew Zealand, Australia
-
Prehospital Center, Region ZealandCompletedOut-Of-Hospital Cardiac Arrest | DrowningDenmark
-
Columbia UniversityNational Cancer Institute (NCI)CompletedDepression | Cancer | Health BehaviorUnited States
-
Boston Scientific CorporationRecruitingHeart Disease, Coronary | High-risk Percutaneous Coronary InterventionUnited States, Sweden
-
Ochsner Health SystemBracco CorporateCompletedMyocardial Infarction | Coronary Artery Disease | Cardiac Risk Factors | Normal Healthy Volunteers Without Chronic Medical ConditionsUnited States
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary RestenosisNew Zealand, Denmark, Poland, Netherlands
-
Northwell HealthRecruitingPreDiabetes | Adolescent Obesity | Diet Habit | Nutritional and Metabolic Diseases | Behavior, Health | Lifestyle Risk ReductionUnited States
-
Hoffmann-La RocheCompleted
-
Array BioPharmaCompletedAML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDSUnited States, Australia, Italy, Spain, France, Switzerland, United Kingdom
-
Endospan Ltd.CompletedAortic Arch AneurysmSwitzerland, Italy, New Zealand
-
Fisher and Paykel HealthcareCompletedObstructive Sleep Apnea | Sleep Disordered BreathingNew Zealand
-
Merck Sharp & Dohme LLCRecruitingPrimary Myelofibrosis | Polycythemia Vera | Thrombocythemia, Essential | Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisAustralia, New Zealand
-
Unity Health TorontoRoche Pharma AGCompletedDyspnea | Acute Heart Failure | Shortness of BreathCanada, United States, New Zealand
-
University of PennsylvaniaPatient-Centered Outcomes Research InstituteCompletedCoronary Disease | Cardiac Arrest | Cardiovascular Risk FactorsUnited States
-
CuraSen Therapeutics, Inc.Active, not recruitingMild Cognitive Impairment, Lewy Body Dementia, Parkinson's Disease Rapid Eye Movement Sleep Behavior Disorder, Parkinson's Disease DementiaAustralia, New Zealand, United Kingdom
-
Memorial Sloan Kettering Cancer CenterWashington University School of Medicine; The Cleveland Clinic; Vanderbilt University...Active, not recruitingThoracic Surgery | Atrial Fibrillation in High Risk PatientsUnited States
-
Verve Therapeutics, Inc.Not yet recruitingHypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial HypercholesterolemiaNew Zealand, United Kingdom
-
Verve Therapeutics, Inc.Active, not recruitingHypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial HypercholesterolemiaNew Zealand, United Kingdom